Fig 3. Changes of HBsAg levels in HIV/HBV-coinfected patients with lamivudine-resistant HBV or lamivudine-susceptible HBV on tenofovir-containing combination antiretroviral therapy.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.